Cochrane Abstracts
Anti‐vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Choroidal Neovascularisation in People With Pathological Myopia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435184/all/Anti‐vascular_endothelial_growth_factor_for_choroidal_neovascularisation_in_people_with_pathological_myopia_New. Accessed 01 October 2023.
Anti‐vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435184/all/Anti‐vascular_endothelial_growth_factor_for_choroidal_neovascularisation_in_people_with_pathological_myopia_New. Accessed October 1, 2023.
Anti‐vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435184/all/Anti‐vascular_endothelial_growth_factor_for_choroidal_neovascularisation_in_people_with_pathological_myopia_New
Anti‐vascular Endothelial Growth Factor for Choroidal Neovascularisation in People With Pathological Myopia [Internet]. In: Cochrane Abstracts. [cited 2023 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435184/all/Anti‐vascular_endothelial_growth_factor_for_choroidal_neovascularisation_in_people_with_pathological_myopia_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia
ID - 435184
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435184/all/Anti‐vascular_endothelial_growth_factor_for_choroidal_neovascularisation_in_people_with_pathological_myopia_New
DB - Evidence Central
DP - Unbound Medicine
ER -
